El Lilly has reported that its antibody treatment was ineffective on patients hospitalized with advanced COVID-19. The company also said that a government-sponsored trial, run by the National Institute of Allergy and Infectious Diseases, would not administer the drug, bamlanivimab, to new participants. (The New York Times)
Among all healthcare workers, nurses in particular are at high risk of contracting COVID-19, according to research from the Centers for Disease Control. Of the healthcare workers who comprised 6% of adults hospitalized with the disease from March through May across 13 states, more than a third were nurses or nursing assistants. (The New York Times)
The CDC will send text messages and surveys to people who receive a coronavirus vaccine in order to detect whatever health problems might arise. Once a vaccine is approved and distributed, the agency will use a smartphone-based program, called V-SAFE, to monitor any adverse real-time health developments, and subsequently make phone calls to any vaccine recipients who report a significant adverse event. (WebMD)
Women who take nonsteroidal anti-inflammatory drugs during the second half of their pregnancies could expose their developing babies to serious health problems, according to the FDA. Pursuant to the new warning, the agency is mandating that labels on the drugs explain that NSAIDs taken at 20 weeks or later could cause rare but serious kidney problems for the fetus. (Washington Post)
Calcium has added Dr. Lazar and Dr. Nezin to its strategic services team. Dr. Lazar will lead medical strategy while Dr. Nezin will lead brand strategy.